We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Itaconix Plc | AQSE:ITX.GB | Aquis Stock Exchange | Ordinary Share | GB00BPK3YZ68 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 170.00 | 160.00 | 180.00 | 170.00 | 170.00 | 170.00 | 0.00 | 06:44:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2023 to Jan 2025
TIDMITX
RNS Number : 8417O
Itaconix PLC
05 October 2023
For immediate release
Itaconix plc
("Itaconix" or the "Company")
Holdings in Company
Itaconix (LSE: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, announces that it was notified on 4 October 2023 of the pending transfer of share certificates ("Shares") held by John R. Shaw (CEO), Laura Denner (CFO) and Dr. Yvon Durant (CTO) to Fidelity Investments as the new registered holder. The transfers will allow these Shares to be held in their individual US brokerage accounts. There is no change to the beneficial ownership of the Shares.
The Shares transferred are as follows:
-- John R. Shaw - 940,411 Shares -- Laura Denner - 255,724 Shares -- Dr. Yvon Durant - 110,489 Shares
A total of 1,306,624 Shares have been transferred, representing approximately 9.7% of the Company's ordinary shares in issue. The transfer is expected to be effective in the coming days.
For further information please contact:
Itaconix plc +1 603 775-4400 John R. Shaw / Laura Denner Belvedere Communications +44 (0) 20 3576 0320 John West / Llew Angus Cavendish Capital Markets Ltd +44 (0) 20 7220 0500 Nominated Adviser & Joint Broker Ed Frisby / Abigail Kelly (Corporate Finance) Andrew Burdis / Sunila de Silva (ECM) Canaccord Genuity Joint Broker Adam James +44 (0) 20 7523 8000
About Itaconix
Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.
www.itaconix.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUVRRRORURRAA
(END) Dow Jones Newswires
October 05, 2023 06:01 ET (10:01 GMT)
1 Year Itaconix Chart |
1 Month Itaconix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
